Literature DB >> 8110972

A retrospective analysis of 94 patients with CIN and false negative cervical smears taken at colposcopy.

A R Beeby1, V Wadehra, P J Keating, T I Wagstaff.   

Abstract

This report investigates the reasons for false negative cervical cytology in 94 out of 630 patients (15%) in whom cervical intraepithelial neoplasia (CIN) was diagnosed on colposcopically directed biopsy. Cervical smears were taken immediately before biopsy and the cases with false negative cytology were compared with those whose cytology was abnormal. Patients with false negative cytology were more likely to have been younger (P < 0.01), to have had fewer pregnancies (P < 0.001), to have had a less severe grade of dyskaryosis on their referral smear (P < 0.001), to have had no endocervical cells on the smear (P < 0.05), to have had a less severe grade of CIN on biopsy (P < 0.001), to have had no punctation visible at colposcopy (P < 0.01), and to have had no mosaic pattern seen at colposcopy (P < 0.05). We found no effect attributable to the patient's menstrual history, the interval between referral smear and colposcopy clinic visit, the smear taker or the type of spatula used to take the smear.

Entities:  

Mesh:

Year:  1993        PMID: 8110972     DOI: 10.1111/j.1365-2303.1993.tb00111.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  4 in total

1.  Papanicolaou test in the detection of high-grade cervical lesions: a re-evaluation based on cytohistologic non-correlation rates in 356 concurrently obtained samples.

Authors:  Bhavini Carns; Oluwole Fadare
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 2.  Management of Papanicolaou test results that lack endocervical cells.

Authors:  Lizette Elumir-Tanner; Meghan Doraty
Journal:  CMAJ       Date:  2011-03-07       Impact factor: 8.262

3.  [Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].

Authors:  P Regitnig; H P Dinges; E Ropp; H Fladerer; F Moinfar; G Breitenecker
Journal:  Pathologe       Date:  2007-09       Impact factor: 1.011

4.  Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing.

Authors:  P Vassilakos; P Petignat; M Boulvain; A Campana
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.